ArticleHypertension research : official journal of the Japanese Society of Hypertension2025
Higher systolic blood pressure difference in left not right upper limb is associated with all-cause mortality risk in a community-based population.
Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Commented on by
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated inter-arm systolic blood pressure difference (IASBPD) and mortality risks in 8628 Chinese community residents from an atherosclerosis cohort. IASBPD was calculated by subtracting the systolic blood pressure of the left arm from that of the right arm. Participants were categorized as |IASBPD| <10 mmHg or ≥10 mmHg. These groups were further subdivided into four categories according to specific IASBPD values. The endpoints included all-cause mortality and cardiovascular mortality. Over a median follow-up of 9.87 years, a total of 442 all-cause and 138 cardiovascular deaths were recorded. Compared to |IASBPD| <10 mmHg group, the |IASBPD| ≥10 mmHg group had a 53% increase in all-cause mortality risk (adjusted HR = 1.53, P = 0.002) and a 71% increase in cardiovascular mortality risk (adjusted HR = 1.71, P = 0.021). When comparing specific IASBPD, no significant increase in all-cause mortality risk was observed in the group with a right arm higher ≥10 mmHg (adjusted HR = 1.17, P = 0.507) or in the group with a left arm higher ≤10 mmHg (adjusted HR = 0.90, P = 0.329). Conversely, the left arm higher >10 mmHg group demonstrated a significant 59% increase in the risk of all-cause mortality (adjusted HR = 1.59, P = 0.013). While the association with cardiovascular mortality was not statistically significant in this subgroup, the trend paralleled that observed for all-cause mortality. In conclusion, an elevated IASBPD is significantly associated with all-cause and cardiovascular mortality risks, with higher IASBPD in the left arm showing a stronger link to all-cause mortality risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.